Health
Scientists identify key molecules that mediate radioresistance in aggressive brain cancer – News-Medical.Net
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of th…
Reviewed by Emily Henderson, B.Sc.Sep 30 2020
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.
Glioblastoma multiforme (GBM), is the most aggressive type of brain cancer. It is treated by radiation therapy combined with chemotherapy. However, even with treatment, the five-year survival rate for GBM is less than 7%. One of the major causes for this is that GBM rapidly …
-
Noosa News19 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News18 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News17 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News18 hours agoGood character references restricted in rape cases in Queensland